The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2026 | Advice for community oncologists referring patients with lymphoma for CAR-T
In this video, Megan Melody, MD, Tampa General Hospital, Tampa, FL, comments on the importance of educating local oncologists about the evolving guidelines for CAR T-cell therapy to ensure patients are referred at the right time. Dr Melody emphasizes the need for early referral of high-risk patients to academic centers, even if they may not ultimately receive CAR-T, to facilitate a smooth transition to second-line treatment options if needed. This interview took place at the 31st Congress of the European Hematology Association (EHA) in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
